06/12/2020
4:18 PM | Onconova Therapeutics (Filer)
| Form DEFA14A
| |
06/10/2020
4:28 PM | Onconova Therapeutics (Filer)
| Form DEFA14A
| |
06/10/2020
4:27 PM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/08/2020
3:18 PM | Onconova Therapeutics (Issuer)
Shoemaker Mary Teresa (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/02/2020
4:29 PM | Onconova Therapeutics (Filer)
| Form DEFA14A
| |
06/02/2020
4:25 PM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/21/2020
4:10 PM | GROOPMAN JEROME (Reporting)
Onconova Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2020
8:19 AM | OLER ABRAHAM N. (Reporting)
Onconova Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2020
8:09 AM | Guerin Mark Patrick (Reporting)
Onconova Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2020
8:07 AM | Fruchtman Steven M (Reporting)
Onconova Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
05/18/2020
11:15 PM | Onconova Therapeutics (Filer)
| Form EFFECT
| |
05/15/2020
3:47 PM | Onconova Therapeutics (Filer)
| Form S-3/A
| |
05/15/2020
3:11 PM | Onconova Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/11/2020
6:56 AM | Onconova Therapeutics (Filer)
| Form DEFA14A
| |
05/11/2020
6:55 AM | Onconova Therapeutics (Filer)
| Form DEFA14A
| |
04/24/2020
4:28 PM | Onconova Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
04/09/2020
4:20 PM | Onconova Therapeutics (Filer)
| Form PRE 14A
| |
02/14/2020
3:53 PM | Onconova Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A
| |
01/23/2020
7:38 AM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/17/2020
4:26 PM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2020
3:06 PM | Onconova Therapeutics (Subject)
SABBY MANAGEMENT, LLC (Filed by)
| Form SC 13G/A
| |
01/10/2020
3:03 PM | ARMISTICE CAPITAL, LLC (Filed by)
Onconova Therapeutics (Subject)
| Form SC 13G
| |
01/03/2020
4:29 PM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2020
8:28 AM | Onconova Therapeutics (Filer)
| Form 424B5
| |
12/26/2019
8:11 AM | Onconova Therapeutics (Issuer)
Woodman Richard Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2019
8:08 AM | OLER ABRAHAM N. (Reporting)
Onconova Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2019
8:07 AM | Fruchtman Steven M (Reporting)
Onconova Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2019
8:06 AM | Guerin Mark Patrick (Reporting)
Onconova Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2019
8:05 AM | Maniar Manoj (Reporting)
Onconova Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2019
3:50 PM | ARMISTICE CAPITAL, LLC (Filed by)
Onconova Therapeutics (Subject)
| Form SC 13G
| |
12/19/2019
3:16 PM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2019
8:22 AM | Onconova Therapeutics (Filer)
| Form 424B5
| |
12/19/2019
8:19 AM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2019
8:07 AM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/10/2019
10:19 AM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/10/2019
7:02 AM | Onconova Therapeutics (Filer)
| Form 424B5
| |
12/09/2019
8:07 AM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2019
3:04 PM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/02/2019
4:12 PM | INTRACOASTAL CAPITAL, LLC (Filed by)
Onconova Therapeutics (Subject)
| Form SC 13G
| |
11/27/2019
7:33 AM | MEHTA VIREN (Reporting)
Onconova Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2019
4:24 PM | Onconova Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G
| |
11/26/2019
6:57 AM | Onconova Therapeutics (Issuer)
Reddy E Premkumar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2019
6:53 AM | MARINO JAMES J (Reporting)
Onconova Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2019
6:51 AM | Fruchtman Steven M (Reporting)
Onconova Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2019
6:50 AM | Guerin Mark Patrick (Reporting)
Onconova Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2019
6:46 AM | OLER ABRAHAM N. (Reporting)
Onconova Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2019
6:00 AM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/25/2019
7:56 AM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/25/2019
7:54 AM | Onconova Therapeutics (Filer)
| Form 424B4
| |
11/21/2019
11:15 PM | Onconova Therapeutics (Filer)
| Form EFFECT
| |
11/21/2019
7:15 AM | Onconova Therapeutics (Filer)
| Form S-1/A
| |
11/21/2019
6:45 AM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/19/2019
4:16 PM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2019
3:05 PM | Onconova Therapeutics (Subject)
TYNDALL CAPITAL PARTNERS L P (Filed by)
| Form SC 13G/A
| |
11/12/2019
4:30 PM | Onconova Therapeutics (Filer)
| Form S-1/A
| |
11/12/2019
4:10 PM | Onconova Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/28/2019
8:59 PM | Onconova Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
10/24/2019
6:44 AM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2019
5:22 PM | MARINO JAMES J (Reporting)
Onconova Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/26/2019
3:16 PM | Onconova Therapeutics (Issuer)
TYNDALL CAPITAL PARTNERS L P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2019
4:41 PM | Armistice Capital Master Fund Ltd. (Reporting)
ARMISTICE CAPITAL, LLC (Reporting)
Boyd Steven (Reporting)
Onconova Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2019
4:31 PM | Armistice Capital Master Fund Ltd. (Reporting)
ARMISTICE CAPITAL, LLC (Reporting)
Boyd Steven (Reporting)
Onconova Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/25/2019
5:40 AM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2019
5:32 AM | Onconova Therapeutics (Filer)
| Form 424B3
| |
09/25/2019
5:28 AM | Onconova Therapeutics (Filer)
| Form 424B3
| |
09/25/2019
5:25 AM | Onconova Therapeutics (Filer)
| Form 424B5
| |
09/24/2019
3:08 PM | Onconova Therapeutics (Issuer)
TYNDALL CAPITAL PARTNERS L P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2019
3:05 PM | Onconova Therapeutics (Issuer)
TYNDALL CAPITAL PARTNERS L P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2019
2:21 PM | 683 Capital Management, LLC (Reporting)
683 Capital Partners, LP (Reporting)
Onconova Therapeutics (Issuer)
Zweiman Ari (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2019
2:20 PM | 683 Capital Management, LLC (Filed by)
Onconova Therapeutics (Subject)
| Form SC 13D/A
| |
09/17/2019
4:26 PM | Onconova Therapeutics (Filer)
| Form 424B5
| |
09/13/2019
4:29 PM | Onconova Therapeutics (Subject)
| Form FWP
| |
09/13/2019
3:24 PM | Onconova Therapeutics (Issuer)
TYNDALL CAPITAL PARTNERS L P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2019
2:51 PM | Onconova Therapeutics (Filer)
| Form 424B5
| |
09/13/2019
2:47 PM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2019
3:16 PM | Onconova Therapeutics (Issuer)
TYNDALL CAPITAL PARTNERS L P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2019
3:10 PM | Onconova Therapeutics (Issuer)
TYNDALL CAPITAL PARTNERS L P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2019
3:46 PM | Onconova Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/14/2019
4:22 PM | Onconova Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2019
6:48 AM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/29/2019
4:27 PM | GROOPMAN JEROME (Reporting)
Onconova Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/29/2019
4:26 PM | Hoffman Michael B (Reporting)
Onconova Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/29/2019
4:25 PM | MARINO JAMES J (Reporting)
Onconova Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/29/2019
4:24 PM | MEHTA VIREN (Reporting)
Onconova Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/29/2019
4:23 PM | Onconova Therapeutics (Issuer)
Reddy E Premkumar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/29/2019
4:21 PM | Onconova Therapeutics (Issuer)
STOVER JACK E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/29/2019
3:47 PM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/11/2019
3:43 PM | Onconova Therapeutics (Issuer)
TYNDALL CAPITAL PARTNERS L P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2019
3:35 PM | Onconova Therapeutics (Issuer)
TYNDALL CAPITAL PARTNERS L P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2019
3:21 PM | Onconova Therapeutics (Issuer)
TYNDALL CAPITAL PARTNERS L P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/19/2019
3:05 PM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2019
7:38 PM | Onconova Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
05/24/2019
4:15 PM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/21/2019
11:15 PM | Onconova Therapeutics (Filer)
| Form EFFECT
| |
05/17/2019
4:13 PM | Onconova Therapeutics (Filer)
| Form S-3/A
| |
05/17/2019
3:37 PM | Onconova Therapeutics (Filer)
| Form 424B2
| |
05/16/2019
3:04 PM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2019
7:15 AM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2019
3:45 PM | Onconova Therapeutics (Filer)
| Form DEF 14A
| |
04/08/2019
6:19 PM | Maniar Manoj (Reporting)
Onconova Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
